Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score
Max Peters(University Medical Center Utrecht), Hashim U. Ahmed(National Health Service), Otto Ettala(University of Turku), Taimur T. Shah(Imperial College Healthcare NHS Trust), Giorgio Gandaglia(Vita-Salute San Raffaele University), Erik Skaaheim Haug(Oslo University Hospital), Peter S.N. van Rossum(Amsterdam University Medical Centers), Tobias Nordström(Karolinska Institutet), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Alberto Martini(The University of Texas MD Anderson Cancer Center), Mathias Winkler(National Health Service), Anna Lantz(Mount Sinai Hospital), Ivan Jambor(University of Turku), Ileana Montoya Perez(University of Turku), Hannu J. Aronen(University Medical Center Utrecht), David Eldred‐Evans(Imperial College London), Edward Bass(Imperial College London), Pekka Taimen(University of Turku), Martin J. Connor(Imperial College Healthcare NHS Trust), Wolfgang Picker, Juha Knaapila(University of Turku), Vito Cucchiara(IRCCS Ospedale San Raffaele), P.H.J. Kurver(University Medical Center Utrecht), Armando Stabile(Royal Free London NHS Foundation Trust), Deepika Reddy(Imperial College London), Nicola Fossati(Ospedale regionale di Lugano), Mariana Bertoncelli Tanaka(Imperial College London), Peter J. Boström(University of Turku), Joost J.C. Verhoeff(University Medical Center Utrecht), Henry Tam(Imperial College London), Stephen Gordon, Kathie Wong(Epsom and St Helier University Hospitals NHS Trust), Hasan Qazi(St George’s University Hospitals NHS Foundation Trust), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia)
Cited by 38
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287